Minirin (Desmopressin)

Desmopressin, the active ingredient in Minirin, is a vasopressin analog presented as a sublingual tablet for sublingual use. It is employed to manage central diabetes insipidus, reduce nocturnal enuresis in children, and provide haemostatic support in mild hemophilia A and von Willebrand disease.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers. Products are shipped in temperature‑controlled packaging where required, and customer support is available 24/7 to address technical queries.

Desmopressin acts on the antidiuretic hormone pathway to control water balance and coagulation. - Central diabetes insipidus: reduces excessive urine output and restores normal fluid balance. - Nocturnal enuresis: decreases nighttime bladder emptying episodes in children. - Mild hemophilia A: improves haemostatic response by raising plasma factor VIII levels. - Von Willebrand disease: enhances clot formation by increasing von Willebrand factor levels.

Desmopressin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: transient gastrointestinal discomfort. - Mild hyponatremia: slight reduction in serum sodium. - Flushing: temporary skin redness.

Serious or Rare Side Effects: - Severe hyponatremia: can lead to seizures or coma. - Water intoxication with cerebral edema. - Allergic reactions: rash, urticaria, or anaphylaxis. - Thrombotic events: rare clot formation in susceptible patients.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients closely. - Serum sodium monitoring: assess baseline and periodic levels to detect hyponatremia. - Fluid restriction: advise patients to limit excessive water intake. - Renal impairment: use caution and increase monitoring in reduced kidney function. - Hypertension: monitor blood pressure as fluid retention may exacerbate condition. - Hypersensitivity: contraindicated in patients with known allergy to desmopressin. - Store at room temperature: keep below 25°C, retain in original packaging, protect from moisture.

Desmopressin can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce desmopressin effectiveness. - Other antidiuretic agents (e.g., chlorpropamide): increase risk of severe hyponatremia. - Vasopressin antagonists (e.g., conivaptan): counteract desmopressin action.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen): may impair renal water excretion, heightening hyponatremia risk. - SSRIs (e.g., fluoxetine): potential additive effect on water retention. - Thiazide diuretics: can exacerbate electrolyte disturbances when combined.